{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T18:19:50Z","timestamp":1788718790299,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bmc.2025.118341","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T03:35:45Z","timestamp":1754451345000},"page":"118341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Synthesis of 1,3-diaryl substituted pyrazole-based imidazo[1,2-a]pyridine carboxamides and evaluation of their antitubercular activity"],"prefix":"10.1016","volume":"129","author":[{"given":"Ojaswitha","family":"Ommi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshada Anil","family":"Bhalerao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradip","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juned","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepanshi","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Nanduri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Sonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunava","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidharth","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata Madhavi","family":"Yaddanapudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118341_bb0005","series-title":"Global tuberculosis report 2024","author":"Organization WH","year":"2024"},{"issue":"11","key":"10.1016\/j.bmc.2025.118341_bb0010","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-022-00731-y","article-title":"Anti-tuberculosis treatment strategies and drug development: challenges and priorities","volume":"20","author":"Dartois","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmc.2025.118341_bb0015","first-page":"141","article-title":"World Tuberculosis Day 2024 theme \u201cYes! We can end TB\u201d; can be made a reality through concerted global efforts that advance detection, diagnosis, and treatment of tuberculosis infection and disease","author":"Goletti","year":"2024","journal-title":"Int J Infect Dis"},{"issue":"23","key":"10.1016\/j.bmc.2025.118341_bb0020","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMoa0808427","article-title":"The diarylquinoline TMC207 for multidrug-resistant tuberculosis","volume":"360","author":"Diacon","year":"2009","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.bmc.2025.118341_bb0025","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa1112433","article-title":"Delamanid for multidrug-resistant pulmonary tuberculosis","volume":"366","author":"Gler","year":"2012","journal-title":"N Engl J Med"},{"issue":"6789","key":"10.1016\/j.bmc.2025.118341_bb0030","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/35016103","article-title":"A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis","volume":"405","author":"Stover","year":"2000","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bmc.2025.118341_bb0035","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1016\/S2666-5247(23)00002-2","article-title":"Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis","volume":"4","author":"Sonnenkalb","year":"2023","journal-title":"Lancet Microbe"},{"issue":"12","key":"10.1016\/j.bmc.2025.118341_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052951","article-title":"Identification of novel imidazo[1,2-a]pyridine inhibitors targeting M. tuberculosis QcrB","volume":"7","author":"Abrahams","year":"2012","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.bmc.2025.118341_bb0045","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1021\/ml200036r","article-title":"Advent of imidazo[1,2-a]pyridine-3-carboxamides with potent multi- and extended drug resistant antituberculosis activity","volume":"2","author":"Moraski","year":"2011","journal-title":"ACS Med Chem Lett"},{"issue":"7","key":"10.1016\/j.bmc.2025.118341_bb0050","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1021\/ml400088y","article-title":"Advancement of imidazo[1,2-a]pyridines with improved pharmacokinetics and nanomolar activity against Mycobacterium tuberculosis","volume":"4","author":"Moraski","year":"2013","journal-title":"ACS Med Chem Lett"},{"issue":"6","key":"10.1016\/j.bmc.2025.118341_bb0055","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1021\/acsinfecdis.5b00154","article-title":"Arrival of imidazo[2,1-b]thiazole-5-carboxamides: potent anti-tuberculosis agents that target QcrB","volume":"2","author":"Moraski","year":"2016","journal-title":"ACS Infect Dis"},{"issue":"9","key":"10.1016\/j.bmc.2025.118341_bb0060","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/nm.3262","article-title":"Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis","volume":"19","author":"Pethe","year":"2013","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.bmc.2025.118341_bb0065","doi-asserted-by":"crossref","first-page":"5293","DOI":"10.1021\/jm5003606","article-title":"Lead optimization of a novel series of imidazo[1,2-a]pyridine amides leading to a clinical candidate (Q203) as a multi- and extensively-drug-resistant anti-tuberculosis agent","volume":"57","author":"Kang","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118341_bb0070","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ejmech.2016.09.082","article-title":"Synthesis and structure-activity studies of side chain analogues of the anti-tubercular agent, Q203","volume":"125","author":"Kang","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118341_bb0075","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ejmech.2017.05.021","article-title":"Synthesis and structure-activity relationships of novel fused ring analogues of Q203 as antitubercular agents","volume":"136","author":"Kang","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118341_bb0080","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ejmech.2019.02.039","article-title":"Synthesis, structure-activity relationship studies and biological characterization of new [1,2,4]triazolo[1,5-a]pyrimidine-based LSD1\/KDM1A inhibitors","volume":"167","author":"Wang","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"12","key":"10.1016\/j.bmc.2025.118341_bb0085","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1021\/acsmedchemlett.6b00330","article-title":"Identification of N-(2-phenoxyethyl)imidazo[1,2-a]pyridine-3-carboxamides as new antituberculosis agents","volume":"7","author":"Wu","year":"2016","journal-title":"ACS Med Chem Lett"},{"issue":"6","key":"10.1016\/j.bmc.2025.118341_bb0090","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1111\/cbdd.13739","article-title":"Design, synthesis, and biological evaluation of novel imidazo[1,2-a]pyridinecarboxamides as potent anti-tuberculosis agents","volume":"96","author":"Onajole","year":"2020","journal-title":"Chem Biol Drug Des"},{"issue":"6","key":"10.1016\/j.bmc.2025.118341_bb0095","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.bmc.2016.01.059","article-title":"Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors","volume":"24","author":"Samala","year":"2016","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2025.118341_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227224","article-title":"Intracellular and in vivo evaluation of imidazo[2,1-b]thiazole-5-carboxamide anti-tuberculosis compounds","volume":"15","author":"Moraski","year":"2020","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.bmc.2025.118341_bb0105","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2174\/1570193X19666220118111614","article-title":"A new insight into the synthesis and biological activities of pyrazole based derivatives","volume":"19","author":"Mor","year":"2022","journal-title":"Mini-Rev Org Chem"},{"issue":"5","key":"10.1016\/j.bmc.2025.118341_bb0110","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1134\/S1070428023050160","article-title":"Synthesis and pharmacological activities of pyrazole and oxadiazole derivatives: a review","volume":"59","author":"Vahora","year":"2023","journal-title":"Russ J Org Chem"},{"issue":"5","key":"10.1016\/j.bmc.2025.118341_bb0115","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.3390\/biomedicines10051124","article-title":"A review of the recent development in the synthesis and biological evaluations of pyrazole derivatives","volume":"10","author":"Ebenezer","year":"2022","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.bmc.2025.118341_bb0120","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s11030-022-10511-8","article-title":"Discovery of newer pyrazole derivatives with potential anti-tubercular activity via 3D-QSAR based pharmacophore modelling, virtual screening, molecular docking and molecular dynamics simulation studies","volume":"27","author":"Modi","year":"2023","journal-title":"Mol Divers"},{"key":"10.1016\/j.bmc.2025.118341_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115548","article-title":"Synthesis, biological screening and in silico studies of new N-phenyl-4-(1,3-diaryl-1H-pyrazol-4-yl)thiazol-2-amine derivatives as potential antifungal and antitubercular agents","volume":"258","author":"Nandurkar","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118341_bb0130","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ejmech.2017.07.059","article-title":"Recent advances of pyrazole-containing derivatives as anti-tubercular agents","volume":"139","author":"Xu","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118341_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107179","article-title":"The first-in-class pyrazole-based dual InhA-VEGFR inhibitors towards integrated antitubercular host-directed therapy","volume":"145","author":"Shaaban","year":"2024","journal-title":"Bioorg Chem"},{"issue":"23","key":"10.1016\/j.bmc.2025.118341_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/cbic.202400414","article-title":"Synthesis and antimycobacterial evaluation of novel pyrazole-isoxazolines and pyrazole-isoxazoles","volume":"25","author":"Moraes","year":"2024","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bmc.2025.118341_bb0145","doi-asserted-by":"crossref","unstructured":"Zala M, Vora JJ, Khedkar VM. Synthesis, characterization, antitubercular activity, and molecular docking studies of pyrazolylpyrazoline-clubbed triazole and tetrazole hybrids. ACS Omega. 2023;8(23): 20262\u201320,271.","DOI":"10.1021\/acsomega.2c07267"},{"issue":"40","key":"10.1016\/j.bmc.2025.118341_bb0150","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202203333","article-title":"Identification of 1,3-substituted pyrazole-based carboxamide derivatives as potent antitubercular agents","volume":"7","author":"Baliram Gaikwad","year":"2022","journal-title":"ChemistrySelect"},{"issue":"7","key":"10.1016\/j.bmc.2025.118341_bb0155","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1039\/D3MD00079F","article-title":"Synthesis and pharmacological evaluation of 1,3-diaryl substituted pyrazole based (thio)urea derivatives as potent antimicrobial agents against multi-drug resistant Staphylococcus aureus and Mycobacterium tuberculosis","volume":"14","author":"Ommi","year":"2023","journal-title":"RSC Med Chem"},{"key":"10.1016\/j.bmc.2025.118341_bb0160","doi-asserted-by":"crossref","DOI":"10.1039\/D4MD00623B","article-title":"Design, synthesis, and biological evaluation of pyrazole\u2013ciprofloxacin hybrids as antibacterial and antibiofilm agents against Staphylococcus aureus","author":"Ommi","year":"2025","journal-title":"RSC Med Chem"},{"issue":"5","key":"10.1016\/j.bmc.2025.118341_bb0165","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1021\/acs.orglett.6b00137","article-title":"CBr4 mediated oxidative CN bond formation: applied in the synthesis of imidazo[1,2-\u03b1]pyridines and imidazo[1,2-\u03b1]pyrimidines","volume":"18","author":"Huo","year":"2016","journal-title":"Org Lett"},{"issue":"35","key":"10.1016\/j.bmc.2025.118341_bb0170","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1039\/D4OB01166J","article-title":"Directed regioselective arylation of imidazo[1,2-a]pyridine-3-carboxamides using Rh(iii) catalysis","volume":"22","author":"Jahan","year":"2024","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2025.118341_bb0175","doi-asserted-by":"crossref","first-page":"0055","DOI":"10.1055\/s-2001-9761","article-title":"Microwave assisted synthesis of 1aryl3-dimethylaminoprop-2-enones: a simple and rapid access to 3(5)-arylpyrazoles","volume":"2001","author":"Pleier","year":"2001","journal-title":"Synthesis-stuttgart."},{"issue":"5","key":"10.1016\/j.bmc.2025.118341_bb0180","doi-asserted-by":"crossref","first-page":"2000349","DOI":"10.1002\/ardp.202000349","article-title":"Design, synthesis, in silico, and in vitro evaluation of 3-phenylpyrazole acetamide derivatives as antimycobacterial agents","volume":"354","author":"Gaikwad","year":"2021","journal-title":"Arch Pharm"},{"issue":"17","key":"10.1016\/j.bmc.2025.118341_bb0185","doi-asserted-by":"crossref","first-page":"8864","DOI":"10.1021\/acs.joc.7b01006","article-title":"Regioselective synthesis, NMR, and crystallographic analysis of N1-substituted pyrazoles","volume":"82","author":"Huang","year":"2017","journal-title":"J Org Chem"},{"issue":"29","key":"10.1016\/j.bmc.2025.118341_bb0190","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.1016\/S0040-4020(03)00858-5","article-title":"A generic approach for the catalytic reduction of nitriles","volume":"59","author":"Caddick","year":"2003","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmc.2025.118341_bb0195","first-page":"10","article-title":"Structure of Mycobacterium tuberculosis cytochrome bcc in complex with Q203 and TB47, two anti-TB drug candidates","author":"Zhou","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.bmc.2025.118341_bb0200","unstructured":"Release S. 1: Glide, Schr\u00f6dinger, LLC, New York, NY, 2021. Schr\u00f6dinger Release. 2021;3."},{"key":"10.1016\/j.bmc.2025.118341_bb0205","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.prostaglandins.2018.02.004","article-title":"Novel piperidine-derived amide sEH inhibitors as mediators of lipid metabolism with improved stability","volume":"136","author":"Pecic","year":"2018","journal-title":"Prostaglandins Other Lipid Mediators"},{"key":"10.1016\/j.bmc.2025.118341_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116777","article-title":"Identification of nitrofuranylchalcone tethered benzoxazole-2-amines as potent inhibitors of drug resistant Mycobacterium tuberculosis demonstrating bactericidal efficacy","volume":"64","author":"Kumar Sahoo","year":"2022","journal-title":"Bioorg Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2025.118341_bb0215","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nat Protoc"},{"issue":"11","key":"10.1016\/j.bmc.2025.118341_bb0220","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1128\/AAC.47.11.3616-3619.2003","article-title":"Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method","volume":"47","author":"Martin","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.bmc.2025.118341_bb0225","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/jac\/dkm207","article-title":"Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis","volume":"60","author":"Taneja","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.bmc.2025.118341_bb0230","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1086\/510431","article-title":"New consensus guidelines from the Clinical and Laboratory Standards Institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria","volume":"44","author":"Jorgensen","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmc.2025.118341_bb0235","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-61779-080-5_20","article-title":"Cell sensitivity assays: the MTT assay","volume":"731","author":"van Meerloo","year":"2011","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"key":"10.1016\/j.bmc.2025.118341_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116289","article-title":"Polycationic phosphorous dendrimer potentiates multiple antibiotics against drug-resistant mycobacterial pathogens","volume":"173","author":"Imran","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.bmc.2025.118341_bb0245","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1038\/s41598-017-11575-5","article-title":"Diphenyleneiodonium chloride (DPIC) displays broad-spectrum bactericidal activity","volume":"7","author":"Pandey","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.bmc.2025.118341_bb0250","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nat Protoc"},{"issue":"1","key":"10.1016\/j.bmc.2025.118341_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"21","key":"10.1016\/j.bmc.2025.118341_bb0260","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212 ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.bmc.2025.118341_bb0265","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/03602532.2021.1970178","article-title":"Drug metabolic stability in early drug discovery to develop potential lead compounds","volume":"53","author":"Gajula","year":"2021","journal-title":"Drug Metab Rev"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625002822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625002822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T04:58:55Z","timestamp":1779771535000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625002822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":53,"alternative-id":["S0968089625002822"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118341","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of 1,3-diaryl substituted pyrazole-based imidazo[1,2-a]pyridine carboxamides and evaluation of their antitubercular activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118341","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118341"}}